Related Experiment Video
Updated: Jul 13, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: July 19, 2024
Blocking fatty acids' mystery tour: a therapy for metabolic syndrome?
1Medical Department, Karl-Landsteiner Institute for Endocrinology and Metabolism, Heinrich-Collin-Strasse 30, A-1140 Vienna, Austria. michael.roden@meduniwien.ac.at
Abstract:
Elevated circulating fatty acids are associated with impaired insulin action and inflammation. During intracellular transit, fatty acids use fatty acid-binding proteins (FABPs) as shuttles. A recent study (Furuhashi et al., 2007) explores inhibiting FABP4/aP2 as a strategy for treating atherosclerosis and type 2 diabetes.
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Fats as Energy Storage Molecules
Fats as Energy Storage Molecules